Niels W C J van de Donk Selected Research

Niels W C J van de Donk Research Topics

Disease

112	Multiple Myeloma 04/2024 - 11/2003
31	Neoplasms (Cancer) 04/2024 - 11/2003
7	Infections 03/2024 - 01/2020
7	Lymphoma (Lymphomas) 01/2022 - 11/2003
6	Disease Progression 07/2023 - 03/2016
4	Residual Neoplasm 01/2023 - 01/2021
4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2021 - 01/2018
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 07/2023 - 01/2022
3	Cytokine Release Syndrome 01/2023 - 11/2020
3	Body Weight (Weight, Body) 12/2022 - 09/2015
3	Hematologic Neoplasms (Hematological Malignancy) 07/2021 - 03/2016
3	Monoclonal Gammopathy of Undetermined Significance 01/2021 - 06/2014
3	Chromosome Aberrations (Chromosome Abnormalities) 12/2020 - 09/2012
2	Neutropenia 11/2023 - 10/2021
2	COVID-19 01/2023 - 01/2020
2	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2021 - 10/2010
2	Smoldering Multiple Myeloma 01/2021 - 01/2020
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2018 - 01/2016
2	Anemia 10/2015 - 09/2012
1	Fever (Fevers) 11/2023
1	Sudden Death 09/2023
1	Polyneuropathies (Polyneuropathy) 09/2023
1	Ageusia (Hypogeusia) 08/2023
1	Uveal melanoma 01/2023
1	Sepsis (Septicemia) 11/2022
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022
1	Lymphopenia (Lymphocytopenia) 10/2021
1	Septic Shock (Toxic Shock Syndrome) 10/2021
1	Hypertension (High Blood Pressure) 10/2021
1	Fibrosis (Cirrhosis) 04/2021

Drug/Important Bio-Agent (IBA)

42	daratumumabIBA 12/2023 - 02/2015
18	Monoclonal AntibodiesIBA 12/2023 - 10/2014
16	Lenalidomide (CC 5013)FDA Link 12/2023 - 06/2011
15	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 04/2024 - 01/2020
14	B-Cell Maturation AntigenIBA 04/2024 - 01/2020
13	AntibodiesIBA 11/2023 - 03/2016
12	Bispecific AntibodiesIBA 04/2024 - 11/2020
12	Chimeric Antigen ReceptorsIBA 01/2024 - 01/2016
10	Dexamethasone (Maxidex)FDA LinkGeneric 12/2023 - 11/2003
9	Bortezomib (Velcade)FDA Link 12/2023 - 04/2006
9	AntigensIBA 11/2023 - 01/2017
7	CytokinesIBA 04/2024 - 01/2016
7	Proteasome InhibitorsIBA 11/2022 - 08/2013
6	Proteins (Proteins, Gene)FDA Link 01/2024 - 06/2014
6	Thalidomide (Thalomid)FDA Link 09/2023 - 04/2006
6	pomalidomideIBA 11/2022 - 01/2018
5	ixazomibIBA 09/2023 - 01/2018
4	Immunoconjugates (Immunoconjugate)IBA 01/2023 - 01/2020
4	Immunomodulating AgentsIBA 11/2022 - 08/2013
3	EpitopesIBA 07/2023 - 03/2016
3	Prednisone (Sone)FDA LinkGeneric 09/2018 - 03/2016
3	Lovastatin (Mevacor)FDA LinkGeneric 01/2006 - 11/2003
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2024 - 01/2021
2	Surface Antigens (Surface Antigen)IBA 01/2024 - 01/2017
2	VaccinesIBA 12/2023 - 01/2023
2	Immunoglobulin G (IgG)IBA 11/2023 - 06/2014
2	Melphalan (Alkeran)FDA LinkGeneric 01/2022 - 03/2016
2	elotuzumabIBA 11/2020 - 01/2018
2	SurvivinIBA 01/2020 - 10/2013
2	isatuximabIBA 01/2019 - 01/2018
2	felzartamabIBA 01/2019 - 01/2018
2	Immune Checkpoint InhibitorsIBA 01/2019 - 01/2018
2	ADP-ribosyl Cyclase 1IBA 01/2019 - 01/2017
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2018 - 11/2016
2	Antigen Receptors (Antigen Receptor)IBA 01/2017 - 01/2016
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2006 - 01/2006
1	Fc Receptors (Fc Receptor)IBA 01/2024
1	Intravenous Immunoglobulins (IVIG)FDA Link 12/2023
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2023
1	Keratins (Keratin)IBA 08/2023
1	molnupiravirIBA 01/2023
1	remdesivirIBA 01/2023
1	crisamicin AIBA 01/2023
1	Peptide FragmentsIBA 01/2023
1	Antiviral Agents (Antivirals)IBA 01/2023
1	Dihydrotachysterol (AT 10)IBA 01/2023
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023
1	CreatinineIBA 01/2023
1	nirmatrelvir and ritonavir drug combinationIBA 01/2023
1	RNA (Ribonucleic Acid)IBA 12/2022
1	tetraethylpyrazine (TEP)IBA 12/2022
1	iberdomideIBA 11/2022
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2022
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 12/2021
1	SolutionsIBA 11/2021
1	Peptides (Polypeptides)IBA 11/2021
1	Granzymes (Granzyme)IBA 10/2021
1	durvalumabIBA 05/2021
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2021
1	GlycolipidsIBA 01/2021
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 01/2021

Therapy/Procedure

32	Therapeutics 03/2024 - 06/2015
10	Immunotherapy 01/2024 - 10/2013
9	Stem Cell Transplantation 01/2022 - 04/2006
3	Transplantation 12/2023 - 01/2017
3	Drug Therapy (Chemotherapy) 01/2017 - 04/2006
2	Radiotherapy 11/2018 - 10/2010
1	Aftercare (After-Treatment) 10/2023
1	Subcutaneous Injections 11/2022